Survival Benefit of Palliative Oophorectomy for Patients With Ovarian Metastasis From Baseline Metastatic Gastric Adenocarcinoma
To our knowledge, this is the largest multiethnic population study assessing SB of PO in patients with GA with OM. Additionally, it is the largest study analyzing survival in this population according to the patient's multiethnic characteristics and metastasis timing and growth patterns. PO presents as a therapeutic option for women with GAs with OM if the patient is clinically suitable for surgical resection.
Authors
- Larissa A. Meyer (ORCID: https://orcid.org/0000-0002-2687-7463)
- Ahmed Abdelhakeem (ORCID: https://orcid.org/0000-0001-7186-1332)
- Kohei Yamashita (ORCID: https://orcid.org/0000-0001-8790-9265)
- Katsuhiro Yoshimura
- Matheus Sewastjanow‐Silva (ORCID: https://orcid.org/0000-0003-4804-1891)
- Tara Sagebiel (ORCID: https://orcid.org/0000-0001-5700-0042)
- Brian D. Badgwell (ORCID: https://orcid.org/0000-0002-9915-8355)
- Jaffer A. Ajani (ORCID: https://orcid.org/0000-0001-9946-0629)
- Cindy M. Pabon (ORCID: https://orcid.org/0000-0002-9755-9374)
- Lianchun Xiao (ORCID: https://orcid.org/0000-0003-0972-2766)
- M Murphy (ORCID: https://orcid.org/0000-0002-4310-3590)
- Naruhiko Ikoma (ORCID: https://orcid.org/0000-0002-9825-9234)
- Prajnan Das (ORCID: https://orcid.org/0000-0002-3845-0707)
- Jing Li (ORCID: https://orcid.org/0000-0003-0882-9860)
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1200/jco-24-01678
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.52